December 18, 2017 / 7:03 AM / 8 months ago

BRIEF-Sensorion And Cochlear Announce Collaboration To Study Combination Therapies For Cochlear Implant Patients

Dec 18 (Reuters) - Sensorion Sa:

* SENSORION AND COCHLEAR ANNOUNCE COLLABORATION TO STUDY COMBINATION THERAPIES FOR COCHLEAR IMPLANT PATIENTS

* COCHLEAR LTD SAYS SENSORION, CO WILL EVALUATE SENS-401 IN COMBINATION WITH COCHLEAR’S COCHLEAR IMPLANTS IN PRECLINICAL SETTING IN 2018

* COCHLEAR SAYS POTENTIAL MID-STAGE CLINICAL TESTING FOR SENS-401 IN COMBINATION WITH COCHLEAR’S COCHLEAR IMPLANTS TO BEGIN AS SOON AS 2019

* COCHLEAR - WILL INVEST €1.6 MILLION AND RECEIVE AN EQUITY STAKE IN SENSORION

* COCHLEAR - WILL GET A RIGHT OF FIRST NEGOTIATION FOR SENS-401 GLOBAL USE IN COMBINATION WITH CERTAIN IMPLANTABLE DEVICES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below